The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology. - Haverkamp,W.; Breithardt,G.; Camm,AJ.; Janse,MJ.; Rosen,MR.; Antzelevitch,C.; Escande,D.; Franz,M.; Malik,M.; Moss,A.; Shah,R. (Eur Heart J, 2000)